Please note that the below organisations and initiatives are not affiliated with BRAIN UK.

Brain Tumour Research Novel Therapeutics Accelerator (BTR-NTA)

For tumour based studies, once your project has finished, you may want to consider the Brain Tumour Research Novel Therapeutics Accelerator (BTR-NTA) programme. Funded by our funder, Brain Tumour Research, the BTR-NTA is an accelerator programme that provides independent and holistic guidance to help researchers position their therapeutic or technology along a realistic pathway to clinical trials. The BTR-NTA welcomes applications from academic and industry researchers developing any type of therapeutic (including delivery technologies) for patients with a brain tumour.

Children’s Brain Tumour Network (CBTN)

Dedicated to driving innovative discovery, pioneering new treatments and accelerating open science to improve health for all children and young adults diagnosed with a brain tumour. By accelerating the pace of translational research and the discovery of new treatments, they are a global community with the shared goal to save children and young adults from brain tumours. Data and biospecimen samples, cell lines, and models are available for request, representing more than 30 childhood brain tumour subtypes, including some of the rarest childhood tumour classifications. CBTN is committed to sharing these data and specimens broadly at no cost to researchers. More than 100 tumour cell lines are available for use in pre-clinical testing.